Masaki Inoue, Yuta Tsuji, Reira Ueno, Daisuke Miyamoto, Keisuke Tanaka, Yuka Moriyasu, Saya Shibata, Mei Okuda, Daisuke Ando, Yasuhiro Abe, et al. Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells. Scientific reports. 2023. 13. 1. 13762-13762
Masaki Inoue, Kanako Yamashita, Yuta Tsuji, Midori Miki, Shota Amano, Taichi Okumura, Koki Kuge, Takao Tone, Shota Enomoto, Chinatsu Yoshimine, et al. Characterization of a TNFR2-Selective Agonistic TNF-α Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander. The Journal of Immunology. 2021. 206. 8. 1740-1751
Masaki Inoue, Yuta Tsuji, Chinatsu Yoshimine, Shota Enomoto, Yuki Morita, Natsuki Osaki, Masahiro Kunishige, Midori Miki, Shota Amano, Kanako Yamashita, et al. Structural optimization of a TNFR1-selective antagonistic TNFα mutant to create new-modality TNF-regulating biologics. The Journal of biological chemistry. 2020. 295. 28. 9379-9391
Yamashita T, Kamada H, Kanasaki S, Nagano K, Inoue M, Higashisaka K, Yoshioka Y, Tsutsumi Y, Tsunoda S. Ephrin type-A receptor 2 on tumor-derived exosomes enhances angiogenesis throuth the activation of MAPK signaling. Pharmazie. 2019. 74. 10. 614-619
Shimojo M, Kasahara Y, Inoue M, Tsunoda SI, Shudo Y, Kurata T, Obika S. A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer. Scientific reports. 2019. 9. 1. 7618-7618